NYSCF Scientists One Step Closer to Cell Replacement Therapies for MS

For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.  

These stem cell lines will allow researchers to “turn back the clock” and observe how multiple sclerosis develops and progresses, potentially revealing the onset of the disease at a cellular level long before any symptoms are displayed. The improved protocol for deriving oligodendrocyte cells will also provide a platform for disease modeling, drug screening, and for replacing the damaged cells in the brain with healthy cells generated using this method.

Original publish date: July 24, 2014

 

Read the press release >>

Read the paper in Stem Cell Reports >>

 

Featured in Neurology Today (09/05/2014)

Read the story in Neurology Today >>

Read more about the paper in Stem Cell Reports >>

You are here: News Press Releases NYSCF Scientists One Step Closer to Cell Replacement Therapies for MS